SHOX2 and cancer: By using the optimal methylation cutoff value for individual genes, the positive detection rates of each marker in malignant tumor patients ranked from high to low were 46.3% (HOXA9), 45.1% (SHOX2), 31.1% (SEPTIN9) and 18.9% (RASSF1A).